These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37524147)

  • 1. Early pregnancy loss medical management in clinical practice.
    Baker CC; Wu BT; Han G; Flynn AN; Creinin MD
    Contraception; 2023 Oct; 126():110134. PubMed ID: 37524147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
    Gatter M; Cleland K; Nucatola DL
    Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss.
    Schreiber CA; Creinin MD; Atrio J; Sonalkar S; Ratcliffe SJ; Barnhart KT
    N Engl J Med; 2018 Jun; 378(23):2161-2170. PubMed ID: 29874535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective cohort study comparing success of medical management of early pregnancy loss in pregnancies conceived with and without medical assistance.
    Colleselli-Türtscher V; Hafenmayr M; Ciresa-König A; Trinker M; Maier S; Toth B; Seeber B
    Fertil Steril; 2024 May; 121(5):824-831. PubMed ID: 38211763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of early pregnancy loss with mifepristone and misoprostol in emergency departments compared to a Complex Family Planning office: Implementation of a COVID-19 institutional policy change.
    Bleck RR; Danvers AA; Nimbvikar A; Gurney EP
    Contraception; 2024 Aug; 136():110467. PubMed ID: 38641155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing and efficacy of mifepristone pretreatment for medical management of early pregnancy loss.
    Flynn AN; Roe AH; Koelper N; McAllister A; Sammel MD; Schreiber CA
    Contraception; 2021 Jun; 103(6):404-407. PubMed ID: 33476659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of a hospital outpatient day procedure for medication abortion at 13-18 weeks gestation: Findings from Nepal
    Blum J; Karki C; Tamang A; Shochet T; Shrestha A; Tuladhar H; Karki A; Sharma J; Abbas DF; Dragoman M; Winikoff B
    Contraception; 2019 Dec; 100(6):451-456. PubMed ID: 31491379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone and misoprostol for early abortion when no gestational sac is present.
    Schaff EA; Fielding SL; Eisinger S; Stadalius L
    Contraception; 2001 May; 63(5):251-4. PubMed ID: 11448464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplified medical abortion screening: a demonstration project.
    Raymond EG; Tan YL; Comendant R; Sagaidac I; Hodorogea S; Grant M; Sanhueza P; Van Pratt E; Gillespie G; Boraas C; Weaver MA; Platais I; Bousieguez M; Winikoff B
    Contraception; 2018 Apr; 97(4):292-296. PubMed ID: 29170088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mifepristone and Misoprostol for Early Pregnancy Loss and Medication Abortion.
    Macnaughton H; Nothnagle M; Early J
    Am Fam Physician; 2021 Apr; 103(8):473-480. PubMed ID: 33856168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting.
    Warden S; Genkin I; Hum S; Dunn S
    J Obstet Gynaecol Can; 2019 May; 41(5):647-652. PubMed ID: 31007171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of mifepristone pretreatment on bleeding and pain during medical management of early pregnancy loss.
    Roe AH; McAllister A; Flynn AN; Martin B; Jiang E; Koelper N; Schreiber CA
    Contraception; 2021 Oct; 104(4):432-436. PubMed ID: 33930380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding pattern after medical management of early pregnancy loss with mifepristone-misoprostol and its prognostic value: a prospective observational cohort study.
    Enzelsberger SH; Wetzlmair D; Hermann P; Wagner H; Shebl O; Oppelt P; Trautner PS
    Arch Gynecol Obstet; 2022 Aug; 306(2):349-355. PubMed ID: 34694431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64-70 and 71-77 days of gestation: A retrospective chart review.
    Dzuba IG; Castillo PW; Bousiéguez M; Lugo Hernández EM; Castañeda Vivar JJ; Sanhueza Smith P
    Contraception; 2020 Aug; 102(2):104-108. PubMed ID: 32474060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial.
    Sonalkar S; Koelper N; Creinin MD; Atrio JM; Sammel MD; McAllister A; Schreiber CA
    Am J Obstet Gynecol; 2020 Oct; 223(4):551.e1-551.e7. PubMed ID: 32305259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe.
    Guengant JP; Bangou J; Elul B; Ellertson C
    Contraception; 1999 Sep; 60(3):167-72. PubMed ID: 10640161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for unsuccessful medical abortion with mifepristone and misoprostol.
    Haimov-Kochman R; Arbel R; Sciaky-Tamir Y; Brzezinski A; Laufer N; Yagel S
    Acta Obstet Gynecol Scand; 2007; 86(4):462-6. PubMed ID: 17486469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.